The time for individualizing blood pressure goals has arrived

Barrios, V.; Escobar, C.

doi:10.1016/j.hipert.2016.05.001

array:23 ["pii" => "S1889183716300101" "issn" => "18891837" "doi" => "10.1016/j.hipert.2016.05.001" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "283" "copyright" => "SEH-LELHA" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Hipertens Riesgo Vasc. 2016;33:115-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 11 "formatos" => array:2 [ "HTML" => 10 "PDF" => 1 ] ] "itemSiguiente" => array:18 [ "pii" => "S1889183716300113" "issn" => "18891837" "doi" => "10.1016/j.hipert.2016.05.002" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "284" "copyright" => "SEH-LELHA" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "lit" "cita" => "Hipertens Riesgo Vasc. 2016;33:117-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 11 "formatos" => array:2 [ "HTML" => 10 "PDF" => 1 ] ] "es" => array:8 [ "idiomaDefecto" => true "cabecera" => "Resúmenes" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "117" "paginaFinal" => "121" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1338 "Ancho" => 2315 "Tamanyo" => 162974 ] ] "descripcion" => array:1 [ "es" => "Vías patogénicas de la trombomodulina en la preeclampsia." ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183716300113?idApp=UINPBA00004N" "url" => "/18891837/0000003300000003/v1_201607120024/S1889183716300113/v1_201607120024/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1889183715001087" "issn" => "18891837" "doi" => "10.1016/j.hipert.2015.12.002" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "269" "copyright" => "SEH-LELHA" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Hipertens Riesgo Vasc. 2016;33:114-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 25 "formatos" => array:2 [ "HTML" => 24 "PDF" => 1 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Carta al Director" "titulo" => "Enfermedad arterial periférica: una preocupación creciente en mujeres hipertensas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "114" "paginaFinal" => "115" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Peripheral arterial disease: An increasing concern in hypertensive women" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Barochiner, L.S. Aparicio, M.A. Rada, G.D. Waisman" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Barochiner" ] 1 => array:2 [ "nombre" => "L.S." "apellidos" => "Aparicio" ] 2 => array:2 [ "nombre" => "M.A." "apellidos" => "Rada" ] 3 => array:2 [ "nombre" => "G.D." "apellidos" => "Waisman" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183715001087?idApp=UINPBA00004N" "url" => "/18891837/0000003300000003/v1_201607120024/S1889183715001087/v1_201607120024/es/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "The time for individualizing blood pressure goals has arrived" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "115" "paginaFinal" => "116" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "V. Barrios, C. Escobar" "autores" => array:2 [ 0 => array:4 [ "nombre" => "V." "apellidos" => "Barrios" "email" => array:1 [ 0 => "vivenciobarrios@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "C." "apellidos" => "Escobar" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Cardiology Department, Hospital Ramón y Cajal, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Cardiology Department, Hospital La Paz, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La hora para individualizar los objetivos de presión arterial ha llegado" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1443 "Ancho" => 2392 "Tamanyo" => 213827 ] ] "descripcion" => array:1 [ "en" => "Blood pressure targets according to the clinical characteristics of patients with hypertension." ] ] ] "textoCompleto" => "In the recent meta-analysis of Ettehad et al., authors found that lowering blood pressure (BP) to systolic BP <130mmHg was beneficial, and that this beneficial effect on major cardiovascular events was independent of baseline disease history.<a class="elsevierStyleCrossRef" href="#bib0040">1</a>These results were in the line of the SPRINT trial, in which reducing systolic BP to a goal <120mmHg in high risk hypertensives resulted in lower rates of major cardiovascular events and all-cause death as compared with <140mmHg.<a class="elsevierStyleCrossRef" href="#bib0045">2</a> In addition, a recent meta-analysis also showed that intensive BP lowering provided greater vascular protection than standard regimens, particularly in high-risk patients.<a class="elsevierStyleCrossRef" href="#bib0050">3</a>However, current guidelines recommend more relaxed targets than those observed in these studies, likely due to the lack of solid evidences at the moment these recommendations were performed and the possibility that an excessive BP reduction could be harmful in some fragile patients.<a class="elsevierStyleCrossRefs" href="#bib0055">4,5</a>Remarkably, not all patients are the same. For example, it is not the same a hypertensive patient with diffuse coronary artery disease than other with only one coronary lesion that is effectively revascularized. Despite both patients have hypertension and ischemic heart disease, and current BP goals do not differ among them,<a class="elsevierStyleCrossRefs" href="#bib0065">6,7</a> it is likely that an intensive BP reduction could be harmful in the first case, but not in the second. As a result, we consider that since it is not possible to perform a clinical trial including every individual case, BP goals should be individualized according to the different clinical conditions of patients (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia>Conflict of interestThe authors declare no conflict of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1443 "Ancho" => 2392 "Tamanyo" => 213827 ] ] "descripcion" => array:1 [ "en" => "Blood pressure targets according to the clinical characteristics of patients with hypertension." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Ettehad" 1 => "C.A. Emdin" 2 => "A. Kiran" 3 => "S.G. Anderson" 4 => "T. Callender" 5 => "J. Emberson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(15)01225-8" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2016" "volumen" => "387" "paginaInicial" => "957" "paginaFinal" => "967" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26724178" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial of intensive versus standard blood-pressure control" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.T. Wright Jr." 1 => "J.D. Williamson" 2 => "P.K. Whelton" 3 => "J.K. Snyder" 4 => "K.M. Sink" 5 => "M.V. Rocco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1511939" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2015" "volumen" => "373" "paginaInicial" => "2103" "paginaFinal" => "2116" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26551272" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "X. Xie" 1 => "E. Atkins" 2 => "J. Lv" 3 => "A. Bennett" 4 => "B. Neal" 5 => "T. Ninomiya" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(15)00805-3" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2016" "volumen" => "387" "paginaInicial" => "435" "paginaFinal" => "443" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26559744" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Mancia" 1 => "R. Fagard" 2 => "K. Narkiewicz" 3 => "J. Redón" 4 => "A. Zanchetti" 5 => "M. Böhm" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.hjh.0000431740.32696.cc" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2013" "volumen" => "31" "paginaInicial" => "1281" "paginaFinal" => "1357" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23817082" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.A. James" 1 => "S. Oparil" 2 => "B.L. Carter" 3 => "W.C. Cushman" 4 => "C. Dennison-Himmelfarb" 5 => "J. Handler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2013.284427" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2014" "volumen" => "311" "paginaInicial" => "507" "paginaFinal" => "520" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24352797" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Rosendorff" 1 => "D.T. Lackland" 2 => "M. Allison" 3 => "W.S. Aronow" 4 => "H.R. Black" 5 => "R.S. Blumenthal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIR.0000000000000207" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2015" "volumen" => "131" "paginaInicial" => "e435" "paginaFinal" => "e470" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25829340" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood pressure goals revisited" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V. Barrios" 1 => "C. Escobar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "J. Hypertens." "fecha" => "2016" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/18891837/0000003300000003/v1_201607120024/S1889183716300101/v1_201607120024/en/main.assets" "Apartado" => array:4 [ "identificador" => "16615" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al director" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/18891837/0000003300000003/v1_201607120024/S1889183716300101/v1_201607120024/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183716300101?idApp=UINPBA00004N"]

ISSN: 1889-1837

Hipertensión y riesgo vascular es la Publicación Oficial de la Sociedad Española de Hipertensión y Riesgo Vascular y la Sociedad Argentina de Hipertensión Arterial. La revista constituye un foro para los científicos, especialistas y profesionales de la salud, cuyas actividades están relacionadas con la hipertensión arterial. Debido a la naturaleza multidisciplinaria de esta área, y a la variedad de mecanismos biológicos subyacentes en la hipertensión, la revista cubre diferentes disciplinas relacionadas con la especialidad, lo que la convierte en una publicación de altísimo grado de interés para todos los profesionales relacionados con esta patología. Publica artículos de Investigación, Originales, Revisiones, Casos clínicos, Aplicación práctica, y Resúmenes comentados a la bibliografía internacional, entre otros.

Ver más Opción Open Access

Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

Indexada en:

Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME

Artículo

Opciones para acceder a los textos completos de la publicación Hipertensión y Riesgo Vascular

Suscriptor

Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".

Suscribirse a:

Hipertensión y Riesgo Vascular

Más información

Comprar

Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora

Contactar

Teléfono para suscripciones e incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España

932 415 960

Llamadas desde fuera de España

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Indexada en:

Síguenos:

Suscribirse:

Artículo

Indexada en:

Síguenos:

Suscribirse:

Artículo

Suscríbase a la newsletter